Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 SEK | -0.97% | +2.22% | -54.11% |
Mar. 01 | Sana Biotechnology Shares Rise as Q4 Non-GAAP Net Loss Narrows | MT |
Mar. 01 | Sector Update: Health Care Stocks Edge Higher Premarket Friday | MT |
Sales 2023 | 16.84M 1.54M | Sales 2024 * | 62M 5.68M | Capitalization | 205M 18.74M |
---|---|---|---|---|---|
Net income 2023 | -95M -8.7M | Net income 2024 * | -37M -3.39M | EV / Sales 2023 | 15.3 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 3.3 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 23 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 61.03% |
1 day | -0.97% | ||
1 week | +2.22% | ||
Current month | -4.56% | ||
1 month | -4.56% | ||
3 months | -14.42% | ||
6 months | -65.54% | ||
Current year | -54.11% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 10-12-31 | |
Thomas Feldthus
CEO | Chief Executive Officer | 64 | 10-12-31 |
Jørgen Drejer
FOU | Founder | 69 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jørgen Drejer
FOU | Founder | 69 | 10-12-31 |
Director/Board Member | 66 | 14-12-31 | |
Anna Ljung
BRD | Director/Board Member | 44 | 18-01-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1.84 | -0.97% | 174,746 |
24-04-26 | 1.858 | +3.22% | 386,306 |
24-04-25 | 1.8 | +1.24% | 141,042 |
24-04-24 | 1.778 | +0.11% | 202,982 |
24-04-23 | 1.776 | -1.33% | 158,143 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 11:22 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-54.11% | 18.85M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- SANION Stock